Vico Therapeutics Competitors and Similar CompaniesClear all
Vico Therapeutics's competitors and similar companies include Taiwan Liposome, Gero, Sanofi Genzyme and Arcutis Biotherapeutics.
 Vico Therapeutics Vico Therapeutics is a company that develops ribonucleic acid (RNA) modulating therapies for rare neurological disorders. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | ||
Founding Date | Founding Date 2019 | Founding Date 1997 | Founding Date 2015 | Founding Date 1981 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Leiden, NL HQ | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Westlake Village, US HQ |
Employees | Employees 474% increase | Employees 1652% decrease | Employees 105 | Employees 9,9041% decrease | Employees 29 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $376.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $36.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit NT$129.8m (FY, 2020) | Gross profit N/A | Gross profit N/A | Gross profit $339.4m (FY, 2025) |
Net income | Net income N/A | Net income (NT$983.3m) (FY, 2020) | Net income N/A | Net income N/A | Net income ($16.1m) (FY, 2025) |
Operating ⚠ | |||||
Patent Applications (US) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 376 (Nov, 2020) | Patent Applications (US) 4 (FY, 2019) |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 605 (Nov, 2020) | Patents (US) 5 (FY, 2019) |
Funding | |||||
Latest funding round | Latest funding round $ 31m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 2.2m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 31m | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised $ 160m |
For sources of this data, please see the company profile
View Company Profiles
Taiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companyGero
HQ
Singapore, SG
Employees
105
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View company
Arcutis Biotherapeutics
HQ
Westlake Village, US
Employees
29
Arcutis Biotherapeutics is a pharmaceutical company.
View company